Clinical Trial Update: Adding Maraviroc to the HAART Regimen of Well Controlled HIV-infected Patients [NA]

View source ↗

Summary

This ClinicalTrials.gov entry reports a completed study assessing the addition of maraviroc to existing HAART regimens in patients with well-controlled HIV infe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Selzentry (Maraviroc)

Snippet

Sponsor: Southern California Institute for Research and Education | Conditions: HIV Infection | NA | Status: COMPLETED